129 related articles for article (PubMed ID: 22594647)
1. Effect of cediranib, an inhibitor of vascular endothelial growth factor receptor tyrosine kinase, in a mouse model of choroidal neovascularization.
Kang S; Park KC; Yang KJ; Choi HS; Kim SH; Roh YJ
Clin Exp Ophthalmol; 2013; 41(1):63-72. PubMed ID: 22594647
[TBL] [Abstract][Full Text] [Related]
2. Anti-angiogenic effect of ALS-L1023, an extract of Melissa officinalis L., on experimental choroidal neovascularization in mice.
Roh YJ; Jee D; Rho CR; Cho WK; Kang S
Clin Exp Ophthalmol; 2016; 44(1):43-51. PubMed ID: 26221970
[TBL] [Abstract][Full Text] [Related]
3. Antiangiogenic effects of tivozanib, an oral VEGF receptor tyrosine kinase inhibitor, on experimental choroidal neovascularization in mice.
Kang S; Roh YJ; Kim IB
Exp Eye Res; 2013 Jul; 112():125-33. PubMed ID: 23701975
[TBL] [Abstract][Full Text] [Related]
4. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
Kim KL; Suh W
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
[TBL] [Abstract][Full Text] [Related]
5. Antiangiogenic effects of axitinib, an inhibitor of vascular endothelial growth factor receptor tyrosine kinase, on laser-induced choroidal neovascularization in mice.
Kang S; Roh CR; Cho WK; Park KC; Yang KJ; Choi HS; Kim SH; Roh YJ
Curr Eye Res; 2013 Jan; 38(1):119-27. PubMed ID: 23013553
[TBL] [Abstract][Full Text] [Related]
6. Effects of an anti-VEGF-A monoclonal antibody on laser-induced choroidal neovascularization in mice: optimizing methods to quantify vascular changes.
Campa C; Kasman I; Ye W; Lee WP; Fuh G; Ferrara N
Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1178-83. PubMed ID: 18326747
[TBL] [Abstract][Full Text] [Related]
7. Blockage of PI3K/mTOR Pathways Inhibits Laser-Induced Choroidal Neovascularization and Improves Outcomes Relative to VEGF-A Suppression Alone.
Ma J; Sun Y; López FJ; Adamson P; Kurali E; Lashkari K
Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3138-44. PubMed ID: 27304845
[TBL] [Abstract][Full Text] [Related]
8. The Antiangiogenic Effects of Gold Nanoparticles on Experimental Choroidal Neovascularization in Mice.
Roh YJ; Rho CR; Cho WK; Kang S
Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6561-6567. PubMed ID: 27918830
[TBL] [Abstract][Full Text] [Related]
9. Identification of a novel vascular endothelial growth factor receptor 2 inhibitor and its effect for choroidal neovascularization in vivo.
Takahashi H; Tamaki Y; Ishii N; Oikawa N; Mizuguchi E; Francis JH; Inoue Y; Iriyama A; Obata R; Yanagi Y
Curr Eye Res; 2008 Nov; 33(11):1002-10. PubMed ID: 19085383
[TBL] [Abstract][Full Text] [Related]
10. A novel vascular endothelial growth factor receptor 2 inhibitor, SU11248, suppresses choroidal neovascularization in vivo.
Takahashi H; Obata R; Tamaki Y
J Ocul Pharmacol Ther; 2006 Aug; 22(4):213-8. PubMed ID: 16910860
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of choroidal neovascularisation in mice by systemic administration of the multikinase inhibitor, sorafenib.
Chung EJ; Yoo S; Lim HJ; Byeon SH; Lee JH; Koh HJ
Br J Ophthalmol; 2009 Jul; 93(7):958-63. PubMed ID: 19028740
[TBL] [Abstract][Full Text] [Related]
12. Antiangiogenic effect of dasatinib in murine models of oxygen-induced retinopathy and laser-induced choroidal neovascularization.
Seo S; Suh W
Mol Vis; 2017; 23():823-831. PubMed ID: 29225458
[TBL] [Abstract][Full Text] [Related]
13. Effect of chromogranin A-derived vasostatin-1 on laser-induced choroidal neovascularization in the mouse.
Maestroni S; Maestroni A; Ceglia S; Tremolada G; Mancino M; Sacchi A; Lattanzio R; Zucchiatti I; Corti A; Bandello F; Zerbini G
Acta Ophthalmol; 2015 May; 93(3):e218-22. PubMed ID: 25271003
[TBL] [Abstract][Full Text] [Related]
14. Endogenous osteopontin involvement in laser-induced choroidal neovascularization in mice.
Fujita N; Fujita S; Ogata N; Matsuoka M; Okada Y; Kon S; Uede T; Saika S
Invest Ophthalmol Vis Sci; 2011 Dec; 52(13):9310-5. PubMed ID: 22058329
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of TNF-alpha reduces laser-induced choroidal neovascularization.
Shi X; Semkova I; Müther PS; Dell S; Kociok N; Joussen AM
Exp Eye Res; 2006 Dec; 83(6):1325-34. PubMed ID: 16959248
[TBL] [Abstract][Full Text] [Related]
16. Investigation of the potential utility of a linomide analogue for treatment of choroidal neovascularization.
Abdel-Rahman MH; Yang Y; Salem MM; Meadows S; Massengill JB; Li PK; Davidorf FH
Exp Eye Res; 2010 Dec; 91(6):837-43. PubMed ID: 21055400
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal anakinra inhibits choroidal neovascular membrane growth in a rat model.
Olson JL; Courtney RJ; Rouhani B; Mandava N; Dinarello CA
Ocul Immunol Inflamm; 2009; 17(3):195-200. PubMed ID: 19585363
[TBL] [Abstract][Full Text] [Related]
18. Differential role of tumor necrosis factor (TNF)-alpha receptors in the development of choroidal neovascularization.
Jasielska M; Semkova I; Shi X; Schmidt K; Karagiannis D; Kokkinou D; Mackiewicz J; Kociok N; Joussen AM
Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):3874-83. PubMed ID: 20335614
[TBL] [Abstract][Full Text] [Related]
19. Antiangiogenic effect of oral 2-methoxyestradiol on choroidal neovascularization in mice.
Funakoshi T; Birsner AE; D'Amato RJ
Exp Eye Res; 2006 Nov; 83(5):1102-7. PubMed ID: 16828472
[TBL] [Abstract][Full Text] [Related]
20. Semaphorin 3A blocks the formation of pathologic choroidal neovascularization induced by transforming growth factor beta.
Bai Y; Liang S; Yu W; Zhao M; Huang L; Zhao M; Li X
Mol Vis; 2014; 20():1258-70. PubMed ID: 25352735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
